The FDA approved raxibacumab injection, from Human Genome Sciences/GSK, on 14 December 2012, to treat inhalational Anthrax, a form of...
The FDA Anti-Infective Drugs Advisory Committee (AIDAC) voted 16-1, with one abstention, that animal studies conducted by Human Genome Sciences...